𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas

✍ Scribed by Benjamin Köhler; Marietta Wolter; Britta Blaschke; Guido Reifenberger


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
52 KB
Volume
111
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


KLF6, a putative tumor suppressor gene,
✍ Yung-Ming Jeng; Hey-Chi Hsu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract Gliomas are the most common tumors of the central nervous system and have a grave prognosis. Deletion of chromosome 10p15 is one of the most common chromosomal alterations in gliomas. Recently, a candidate tumor suppressor gene, __KLF6__, which is mapped to chromosome 10p, was found to

Absence of KLF6 gene mutations in human
✍ Pasi A. Koivisto; Xiaohui Zhang; Satu-Leena Sallinen; Pauli Sallinen; Heikki J. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 49 KB 👁 1 views

Loss of heterozygosity (LOH) on chromosome 10 is the most common genetic changes in glioblastomas of World Health Organization (WHO) Grade IV. [1][2][3][4][5][6][7] In most cases, the allelic losses involve loci along the entire chromosome, a finding in line with monosomy 10. LOH on chromosome 10 ma

Functional inactivation of the KLF6 tumo
✍ Olga Camacho-Vanegas; Goutham Narla; Miriam S. Teixeira; Analisa DiFeo; Anjan Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 196 KB 👁 1 views

## Abstract Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor and possesses a high incidence of 10p loss. The KLF6 (Kruppel‐like transcription factor) tumor suppressor gene on 10p15 is inactivated by loss of heterozygosity (LOH) and/or somatic mutation in a number

Mutations of p53 tumor-suppressor gene i
✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana